glycerol sella children 1375 mg suppositories
laboratorio chimico farmaceutico a. sella s.r.l. via vicenza 67 - 36015 schio (vi), italy - suppository - glycerol 1375 mg - drugs for constipation
glycerol suppositories
lab. chimico farmaceutico a sella s.r.l via vicenza 67, schio, italy - glycerol - suppository - glycerol - drugs for constipation
iodine alcoholic cutaneous solution
lab. chimico farmaceutico a sella s.r.l via vicenza 67, schio, italy - potassium iodide, iodine - cutaneous solution - potassium iodide 5 g/100ml iodine 7 g/100ml - antiseptics and disinfectants
cetilsan 3 mg sugar free lozenges
lab. chimico farmaceutico a sella s.r.l via vicenza 67, schio, italy - cetylpyridinium chloride - lozenge - cetylpyridinium chloride 3 mg - throat preparations
fenazil
lab. chimico farmaceutico a sella s.r.l via vicenza 67, schio, italy - promethazine hydrochloride - cream - promethazine hydrochloride 2 % (w/w) - antipruritics, incl. antihistamines, anesthetics, etc.
sodium phosphate sella 16% / 6% rectal solution
laboratorio chimico farmaceutico a. sella s.r.l. via vicenza 67 - 36015 schio (vi), italy - rectal solution - sodium phosphate dibasic heptahydrate 6 g/100ml sodium phosphate monobasic 16 g/100ml - drugs for constipation
lidoproctene 1.5% / 1% cream
laboratorio chimico farmaceutico a. sella s.r.l. via vicenza 67 - 36015 schio (vi), italy - lidocaine hydrochloride, hydrocortisone acetate - cream - lidocaine hydrochloride 1.5 g hydrocortisone acetate 1 g - vasoprotectives
terbinafine liconsa 250 milligram tablets
laboratorios liconsa, s.a. - terbinafine - tablets - 250 milligram - antifungals for systemic use - antifungals for systemic use - it is indicated in the treatment of the following skin and nail fungal infections: treatment of tinea corporis, tinea cruris and tinea pedis, when oral therapy is considered appropriate depending on the site, severity or extent of the infection and for the treatment of onychomycosis caused by dermatophytes
hiprabovis ibr marker live
laboratorios hipra s.a - live ge- tk- double-gene-deleted bovine herpes virus type 1, strain ceddel: 106.3–107.3 ccid50 - immunologicals - cattle - for the active immunisation of cattle from three months of age against bovine herpes virus type 1 (bohv-1) to reduce the clinical signs of infectious bovine rhinotracheitis (ibr) and field virus excretion.onset of immunity: 21 days after completion of the basic vaccination scheme.duration of immunity: 6 months after completion of the basic vaccination scheme
rhiniseng
laboratorios hipra s.a. - inactivated bordetella bronchiseptica, strain 833cer / recombinant type-d pasteurella-multocida toxin (pmtr) - immunologicals - pigs (gilts and sows) - for the passive protection of piglets via colostrum after active immunisation of sows and gilts to reduce the clinical signs and lesions of progressive and non-progressive atrophic rhinitis, as well as to reduce weight loss associated with bordetella-bronchiseptica and pasteurella-multocida infections during the fattening period. challenge studies have demonstrated that passive immunity lasts until piglets are six weeks of age while in clinical field trials, the beneficial effects of vaccination (reduction in nasal lesion score and weight loss) are observed until slaughter.